Arrivo BioVentures
Morrisville, US · Delaware LLC · 1 known investors
Founders & leadership
KA
Karen AdamsNamed on SEC filing
SE
Stephen E. ButtsNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$43.2M disclosed across 1 round · 2023
▶$43.2MraisedNov 2023 · 58 investors · BiotechnologyRule 506(b)
▶$43.2MraisedNov 2023 · 58 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Karen AdamsExecutive Officer
- Stephen E. ButtsExecutive Officer
- Offering amount
- $45.3M
- Amount sold
- $43.2M
- First sale
- Nov 2023
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Arrivo BioVentures's investors?
- Arrivo BioVentures's investors include Rex Health Ventures.
- How much funding has Arrivo BioVentures raised?
- Arrivo BioVentures has disclosed $43.2M raised across 1 round.
- Where is Arrivo BioVentures headquartered?
- Arrivo BioVentures is headquartered in Morrisville, US.